# FDA recall D-0593-2018

> **Bella All Natural** · Class I · drug recall initiated 2018-02-14.

## Product

Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015

## Reason for recall

Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.

## Distribution

Product was distributed in California to online customers and retail stores.

## Key facts

- **Recall number:** D-0593-2018
- **Recalling firm:** Bella All Natural
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-02-14
- **Report date:** 2018-03-14
- **Termination date:** 2019-01-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Los Angeles, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0593-2018

## Citation

> AI Analytics. FDA recall D-0593-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0593-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*